Taxiject Injection 1.0g (Ceftazidime)

Taxiject Injection 1.0g contains ceftazidime, a third-generation cephalosporin antibiotic. This potent medication is designed for intravenous or intramuscular administration to combat severe bacterial infections, particularly those caused by gram-negative organisms.

Uses

Taxiject Injection 1.0g is used to treat a variety of serious bacterial infections, including lower respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, septicemia, and meningitis. It’s particularly effective against Pseudomonas aeruginosa and other resistant gram-negative bacteria.

Benefits

• Broad-spectrum antibiotic activity
• Effective against many resistant gram-negative bacteria
• Treats severe and life-threatening infections
• Can be used for hospital-acquired infections
• Provides rapid and potent antibacterial action

How It Works

Ceftazidime in Taxiject Injection 1.0g works by interfering with bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), enzymes essential for bacterial cell wall construction. This action leads to cell wall weakening and eventual bacterial cell lysis, effectively killing the bacteria.

Dosage

The dosage of Taxiject Injection 1.0g varies depending on the type and severity of infection, patient’s age, weight, and renal function. Typical adult dosages range from 1g to 2g every 8 to 12 hours. Always follow your healthcare provider’s instructions regarding dosage and administration.

Side Effects

Common side effects may include injection site reactions, diarrhea, nausea, and headache. More serious side effects, though rare, can include severe allergic reactions, Clostridium difficile-associated diarrhea, and changes in blood cell counts. Seek medical attention if you experience any severe or persistent side effects.

Warning

Hypersensitivity reactions, including anaphylaxis, can occur. Use with caution in patients with a history of penicillin allergy. Prolonged use may result in overgrowth of non-susceptible organisms. Monitor renal function during treatment, especially in elderly patients or those with pre-existing renal impairment.

Pregnancy and Breastfeeding

Taxiject Injection 1.0g should be used during pregnancy only if clearly needed. Ceftazidime is excreted in human milk in low concentrations. Caution should be exercised when administering to nursing mothers. Consult your healthcare provider for guidance.

Interaction

• May increase the anticoagulant effect of warfarin
• Potential interaction with probenecid, increasing ceftazidime levels
• Can interfere with certain lab tests, including Coombs test
• May enhance the nephrotoxic effects of other medications

Important Information

Inform your healthcare provider about all medications, allergies, and medical conditions before receiving Taxiject Injection 1.0g. This medication is for hospital or clinical use and should be administered by a healthcare professional. Complete the full course of treatment as prescribed, even if symptoms improve, to prevent the development of antibiotic-resistant bacteria. Stay well-hydrated during treatment to help prevent kidney issues.